Apoorva Chaloori joined ICR Westwicke as a Senior Associate with the Life Sciences Investor Relations Team in November 2023.
At ICR Westwicke, she supports senior team members by translating the clinical and commercial potential of her client’s scientific technology and pipelines into investor relation materials such as press releases, corporate presentations, and other company descriptive materials.
Additionally, she supports the senior team members in the construction of investor relations strategies and aids in the setup and execution of client investor relations events, including conferences, earnings calls, and analyst days.
Well versed in scientific and investor communications, Apoorva has previously provided strategic communication support to a number of biotech clients at Solebury Strategic Communications. She has also worked at Spero Therapeutics as a Medical Affairs Associate and completed two Co-Op rotations at GlaxoSmithKline (GSK) with the Drug Product and Analytical and Global Demographics and Diversity Teams.
Apoorva earned an M.Sc. in Biotechnology, with a specialization in Biotechnology Enterprise, from Northeastern University and a B.Sc. in Public Health from Rutgers University.